Metabolic changes detected by ex vivo high resolution 1H NMR spectroscopy in the striatum of 6-OHDA-induced Parkinson's rat

Molecular Neurobiology

Volumn 47, Issue 1, 2013, Pages 123-130

  Gao, Hong Chang ^a   Zhu, Huan ^a   Song, Cai Yong ^a   Lin, Li ^a   Xiang, Yun ^b   Yan, Zhi Han ^a   Bai, Guang Hui ^a   Ye, Fa Qing ^a   Li, Xiao Kun ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Metabolism; Neurotransmitter; Parkinson's disease; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; CREATINE; DOPAMINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; LACTIC ACID; OXIDOPAMINE; SUCCINIC ACID; TAURINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASTROCYTE; CONTROLLED STUDY; CORPUS STRIATUM; EX VIVO STUDY; EXCITOTOXICITY; MALE; METABOLISM; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; REVIEW;

EID: 84872476147     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8336-z     Document Type: Review

References (35)

1. Pearl PL, Hartka TR, Taylor J (2006) Diagnosis and treatment of neurotransmitter disorders. Curr Treat Option NE 8(6):441-450
2. Chassain C, Bielicki G, Durand E, Lolignier S, Essafi F, Traore A, Durif F (2008) Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse. J Neurochem 105(3):874-882
3. Schober A (2004) Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 318(1):215-224
4. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65(2):135-172
5. Luthman J, Fredriksson A, Sundstrom E, Jonsson G, Archer T (1989) Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage. Behav Brain Res 33(3):267-277
6. Chassain C, Bielicki G, Keller C, Renou JP, Durif F (2010) Metabolic changes detected in vivo by 1H MRS in the MPTP-intoxicated mouse. NMR Biomed 23(6):547-553
7. 13C NMS study in the rat. Exp Neurol 191(2):276-284
8. Aguiar LM, Macedo DS, Vasconcelos SM, Oliveira AA, de Sousa FC, Viana GS (2008) CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats. Brain Res 1191:192-199
9. Carta AR, Fenu S, Pala P, Tronci E, Morelli M (2003) Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats. Eur J Neurosci 18(9):2563-2572
10. Nielsen KM, Soghomonian JJ (2004) Normalization of glutamate decarboxylase gene expression in the entopeduncular nucleus of rats with a unilateral 6-hydroxydopamine lesion correlates with increased GABAergic input following intermittent but not continuous levodopa. Neuroscience 123(1):31-42
11. 1H NMR spectroscopy in the human visual cortex. J Cereb Blood Flow Metab 27(5):1055-1063
12. Mangia S, Giove F, Tkac I, Logothetis NK, Henry PG, Olman CA, Maraviglia B, Di Salle F, Ugurbil K (2009) Metabolic and hemodynamic events after changes in neuronal activity: current hypotheses, theoretical predictions and in vivo NMR experimental findings. J Cereb Blood Flow Metab 29(3):441-463
13. Coen M, Lenz EM, Nicholson JK, Wilson ID, Pognan F, Lindon JC (2003) An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem Res Toxicol 16(3):295-303
14. Gao H, Dong B, Liu X, Xuan H, Huang Y, Lin D (2008) Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis. Anal Chim Acta 624(2):269-277
15. 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis. Cancer Sci 100(4):782-785
16. 1H NMR spectroscopy. Neurochem Int 50(2):386-394
17. 2]acetate. J Magn Reson 196(2):157-163
18. 13C nuclear magnetic resonance spectroscopy: a novel approach to the study of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 18(11):1223-1232
19. Globus MY, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg MD (1988) Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J Neurochem 51(5):1455-1464
20. Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, Bernardi G, Finazzi-Agro A, Maccarrone M (2002) Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci 22(16):6900-6907
21. Robertson RG, Graham WC, Sambrook MA, Crossman AR (1991) Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: an intracerebral microdialysis study of gamma-aminobutyric acid in the lateral segment of the globus pallidus. Brain Res 563(1-2):278-280
22. Meshul CK, Allen C (2000) Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion. Synapse 36(2):129-142, (New York, NY
23. Meshul CK, Emre N, Nakamura CM, Allen C, Donohue MK, Buckman JF (1999) Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience 88(1):1-16
24. Matthews CC, Zielke HR, Wollack JB, Fishman PS (2000) Enzymatic degradation protects neurons from glutamate excitotoxicity. J Neurochem 75(3):1045-1052
25. Lewis LD, Ljunggren B, Norberg K, Siesjo BK (1974) Changes in carbohydrate substrates, amino acids and ammonia in the brain during insulin-induced hypoglycemia. J Neurochem 23(4):659-671
26. Tillakaratne NJ, Medina-Kauwe L, Gibson KM (1995) gamma-Aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues. Comp Biochem Physiol A Physiol 112(2):247-263
27. Zhang X, Liu H, Wu J, Liu M, Wang Y (2009) Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in rats. Neurochem Int 54(8):481-487
28. Cruz CJ, Aminoff MJ, Meyerhoff DJ, Graham SH, Weiner MW (1997) Proton MR spectroscopic imaging of the striatum in Parkinson's disease. Magn Reson Imaging 15(6):619-624
29. Davie CA, Wenning GK, Barker GJ, Tofts PS, Kendall BE, Quinn N, McDonald WI, Marsden CD, Miller DH (1995) Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 37(2):204-210
30. 1H-MRS study of an animal model for Parkinson's disease. Magn Reson Imaging 29(1):32-39
31. 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease. J Neurosci 25(7):1691-1700
32. Isaacks RE, Bender AS, Kim CY, Prieto NM, Norenberg MD (1994) Osmotic regulation of myo-inositol uptake in primary astrocyte cultures. Neurochem Res 19(3):331-338
33. Sartorius A, Lugenbiel P, Mahlstedt MM, Ende G, Schloss P, Vollmayr B (2008) Proton magnetic resonance spectroscopic creatine correlates with creatine transporter protein density in rat brain. J Neurosci Methods 172(2):215-219
34. Chih CP, Roberts EL Jr (2003) Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis. J Cereb Blood Flow Metab 23(11):1263-1281
35. Shank RP, Aprison MH (1971) Post mortem changes in the content and specific radioactivity of several amino acids in four areas of the rat brain. J Neurobiol 2(2):145-151